News Center
News CenterHome > News Center

A Letter to Chinese Employees


Dear employees:
On December 18, 2007, Medtronic, Inc. (NYSE:MDT) and Shandong Weigao Group Medical Polymer Company Limited (Hong Kong Stock Exchange: 8199) announced an agreement to form a joint venture to market therapies in the spine and orthopedics sector.
Under the agreement, the joint venture would be a 51-49 partnership between Medtronic and Weigao, to market Medtronic’s spinal products and Weigao’s orthopedic products, which include therapies for the hip, shoulder, spine and trauma. 
Additionally, Medtronic will make an equity investment into Weigao of US $221 million, providing Medtronic a 15 percent stake of the enlarged share capital and the election of two Medtronic nominees to Weigao’s board of directors.  
The signing of the deal marks a new era that represents Weigao and Wegoortho’s business development in the China market, and it especially reflects Wegoortho’s long-term commitment to the orthopedists and patients in China.
Weigao believes that Medtronic is an ideal strategic partner to Wegoortho. Medtronic has advanced technologies, experiences, and trainings that compliments Wegoortho’s broad orthopedic and trauma product line, and Wegoortho can generate synergies with their very strong presence and global reputation . 
Over the past 2 years, Wegoortho could not have grown its business without your solid support. In the future, Medtronic and Wegoortho will work more closely with you and hope to get your bigger support; to together help Chinese patients alleviate pain, restore health, and extend life with our advanced medical technologies and to advance Chinese medical industry. 
Sincerely yours,
Gong Jian Bo
General Manager, Wegoortho
About Medtronic
Medtronic, Inc., ( headquartered in Minneapolis, is the world’s leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease.  Its Internet address is. 
About Weigao 
Weigao ( based in the Shandong province of the People’s Republic of China, is the leading manufacturer in China of medical devices and single-use consumables  including infusion sets, syringes, blood transfusion sets and blood bags as well as orthopedic, cardiovascular stent and blood purification products.

© Weigao group 2020 Lu ICP No. 10205126